BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6605119)

  • 1. Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.
    Laurent MR; Panayi GS
    Ann Rheum Dis; 1983 Oct; 42(5):524-8. PubMed ID: 6605119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of blood picture tests in patients with ankylosing spondylitis].
    MAKAROV MP
    Khirurgiia (Mosk); 1960 Nov; 36():128-31. PubMed ID: 13765593
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential pathogenic role of gut microbiota in rheumatic diseases: a human-centred narrative review.
    Bixio R; Bertelle D; Bertoldo E; Morciano A; Rossini M
    Intern Emerg Med; 2024 Jun; 19(4):891-900. PubMed ID: 38141117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis.
    Ding Y; Xue L
    BMC Musculoskelet Disord; 2022 Sep; 23(1):864. PubMed ID: 36109740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD27
    Wilbrink R; Spoorenberg A; Arends S; van der Geest KSM; Brouwer E; Bootsma H; Kroese FGM; Verstappen GM
    Front Immunol; 2021; 12():686273. PubMed ID: 34168654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.
    Gracey E; Vereecke L; McGovern D; Fröhling M; Schett G; Danese S; De Vos M; Van den Bosch F; Elewaut D
    Nat Rev Rheumatol; 2020 Aug; 16(8):415-433. PubMed ID: 32661321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis.
    Peng YF; Zhang Q; Cao L; Liu Y; Chen D; Sun YK; Zhang ZX
    Int J Clin Exp Med; 2014; 7(12):5289-95. PubMed ID: 25664033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis.
    Kaya T; Bal S; Gunaydin R
    Rheumatol Int; 2007 Feb; 27(4):323-7. PubMed ID: 17021712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis.
    Kaan U; Ferda O
    Rheumatol Int; 2005 Jun; 25(5):357-60. PubMed ID: 14991231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.
    Ritchie RF; Palomaki GE; Neveux LM; Navolotskaia O
    J Clin Lab Anal; 1998; 12(6):371-7. PubMed ID: 9850189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.
    Trull AK; Panayi GS
    Clin Rheumatol; 1983 Dec; 2(4):331-7. PubMed ID: 6430627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.
    Franssen MJ; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1985 Nov; 44(11):766-71. PubMed ID: 4062389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.
    Sanders KM; Hertzman A; Escobar MR; Littman BH
    Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
    Cooper R; Fraser SM; Sturrock RD; Gemmell CG
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies.
    Shinebaum R; Blackwell CC; Forster PJ; Hurst NP; Weir DM; Nuki G
    Br Med J (Clin Res Ed); 1987 Jan; 294(6566):208-10. PubMed ID: 3101813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.
    Feltelius N; Hällgren R; Sjöberg O
    Clin Rheumatol; 1987 Dec; 6(4):545-52. PubMed ID: 2896558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases.
    Yen JH; Liu HW; Lin SF; Chen TP
    Rheumatol Int; 1990; 10(2):71-3. PubMed ID: 2349436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin.
    Reynolds TL; Khan MA; van der Linden S; Cleveland RP
    Ann Rheum Dis; 1991 Mar; 50(3):154-7. PubMed ID: 2015008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spondyloarthropathies and IgA deficiency.
    Taylor HG; Dawes PT
    Ann Rheum Dis; 1991 Dec; 50(12):970. PubMed ID: 1768180
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.
    Taylor HG; Beswick EJ; Dawes PT
    Clin Rheumatol; 1991 Mar; 10(1):43-8. PubMed ID: 1676621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.